Oh, and to be specific as to why this is nonsense - half of the positive trials for ivm used this or a very similar dosing schedule, but people never criticise those for not following FLCCC protocols only the trial with null results
I wonder why 
https://twitter.com/alexandrosM/status/1431611713200087041?s=19 …
-
Show this thread
-
Replying to @GidMK
Half the IVM trials use 3 doses, several days after symptom onset, on empty stomach, on people with additional risk factors, and monitor for 28 days? Can you please indicate those other trials? And ideally which ivm advocate recommends such a protocol.
1 reply 0 retweets 19 likes -
Replying to @alexandrosM
My fave example was the fraudulent Elgazzar trial, but similar (although not always identical) protocols are in Niaee, Babalola, Mahmud etc. The dosages in Niaee are mostly LOWER than in Together by quite a bit
1 reply 1 retweet 29 likes -
-
Replying to @alexandrosM
Lol, why don't you have a look? You're the one who raised this objection about Together in the first place, surely you should've done some basic die diligence beforehand?
3 replies 1 retweet 38 likes -
Replying to @GidMK @alexandrosM
Although worth noting that with Elgazzar retracted the entire mortality benefit for ivermectin in RCTs comes from Niaee et al so if you don't like this dosing schedule you should explain why it's only a problem when the results are null
1 reply 0 retweets 30 likes -
Replying to @GidMK
Alexandros Marinos Retweeted Health Nerd
I'm asking you to back your argument. Feel free to invert the burden though.https://twitter.com/GidMK/status/1431834454046035969?s=19 …
Alexandros Marinos added,
Health NerdVerified account @GidMKOh, and to be specific as to why this is nonsense - half of the positive trials for ivm used this or a very similar dosing schedule, but people never criticise those for not following FLCCC protocols only the trial with null results I wonder why
https://twitter.com/alexandrosM/status/1431611713200087041?s=19 …Show this thread1 reply 0 retweets 17 likes -
Replying to @alexandrosM
Nah, you're just ignoring the substantive point to nit-pick because it's inconvenient
1 reply 0 retweets 50 likes -
Replying to @GidMK
Can you state your substantive point, ideally in ways I can validate?
1 reply 0 retweets 12 likes -
Replying to @alexandrosM
Sure. Many of the positive trials, such as Niaee, have similar dosing schedules as Together. Some of them gave lower doses. But the only trial you have raised this objection to is the one with null results
2 replies 0 retweets 46 likes
Any response here? Why is this dosing regimen an issue for Together but not studies that show positive results?
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.